EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Price:
9.08 USD
-0.22%
Market Closed
Updated:
Jun 11, 2024
EyePoint Pharmaceuticals Inc
Other Liabilities
|
EyePoint Pharmaceuticals Inc
Other Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
|
Other Liabilities
$16.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
25%
|
CAGR 10-Years
12%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Liabilities
$25B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Liabilities
$6.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Liabilities
$25.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Liabilities
$8.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Liabilities
$7.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
See Also
What is EyePoint Pharmaceuticals Inc's Other Liabilities?
Other Liabilities
16.7m
USD
16.7m
USD
Based on the financial report for Mar 31, 2024, EyePoint Pharmaceuticals Inc's Other Liabilities amounts to 16.7m USD.
What is EyePoint Pharmaceuticals Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
12%
12%
Over the last year, the Other Liabilities growth was -15%. The average annual Other Liabilities growth rates for EyePoint Pharmaceuticals Inc have been -5% over the past three years , 25% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
